Absci Corp (NAS:ABSI)
$ 2.77 -0.21 (-7.05%) Market Cap: 342.27 Mil Enterprise Value: 230.64 Mil PE Ratio: 0 PB Ratio: 1.69 GF Score: 54/100

Absci Corp at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 12:10PM GMT
Release Date Price: $1.28 (-5.19%)
Ross Osborn
Cantor Fitzgerald LP - Analyst

Good morning, everyone, and thank you for joining. My name is Ross Osborn. I'm the medtech, life science tools, and diagnostics analyst at Cantor. And today, we are joined by Absci Corporation with Alex Kahn, VP of Finance and Head of Investor Relations.

Questions & Answers

Ross Osborn
Cantor Fitzgerald LP - Analyst

So Alex, would you just provide a brief overview of your Company and yourself for those less familiar with the story?

Alex Khan
Absci Corporation - VP, Finance & IR

Greg. Thank you, Ross, and thank you to Cantor for the opportunity to be here today. And we appreciate it.

So at Absci, we're merging AI with scalable wet lab technologies with a mission to create better biologics for patients faster. And the company that we are today is fundamentally different than where we were at our founding. And even for those who knew us around the time of the IPO, we really evolved a lot since then.

So at our founding, our Founder and CEO,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot